Pharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000-2025

20260 citationsJournal Articlegold Open Access

Authors

Christopher J. Morten · New York Law School

Abstract

This cross-sectional study investigates the size of financial penalties levied by the US government against pharmaceutical companies accused of violating the Anti-Kickback Statute.

Topics & Keywords

Auditing, Earnings Management, Governance Pharmaceutical industry and healthcare Intellectual Property and Patents

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: JAMA Network Open

Volume 9, Issue 3, pp. e261735-e261735

DOI: 10.1001/jamanetworkopen.2026.1735

Field-Weighted Citation Impact: 0.00